Page last updated: 2024-11-02

pifithrin and Liver Steatosis

pifithrin has been researched along with Liver Steatosis in 2 studies

pifithrin: a tetrahydrobenzothiazol; inhibitor of P53 that protects mice from the side effects of cancer therapy; structure in first source

Research Excerpts

ExcerptRelevanceReference
" We tested the efficacy of a p53 inhibitor, pifithrin-α p-nitro (PFT) in attenuating steatosis, associated oxidative stress and apoptosis in a murine model of non-alcoholic fatty liver disease (NAFLD)."3.79Inhibition of p53 attenuates steatosis and liver injury in a mouse model of non-alcoholic fatty liver disease. ( Derdak, Z; Harb, R; Sousa, A; Villegas, KA; Wands, JR; Wu, AM, 2013)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Song, YM1
Lee, WK1
Lee, YH1
Kang, ES1
Cha, BS1
Lee, BW1
Derdak, Z1
Villegas, KA1
Harb, R1
Wu, AM1
Sousa, A1
Wands, JR1

Other Studies

2 other studies available for pifithrin and Liver Steatosis

ArticleYear
Metformin Restores Parkin-Mediated Mitophagy, Suppressed by Cytosolic p53.
    International journal of molecular sciences, 2016, Jan-16, Volume: 17, Issue:1

    Topics: Animals; Benzothiazoles; Caloric Restriction; Cell Survival; Diet; Endoplasmic Reticulum Stress; Fat

2016
Inhibition of p53 attenuates steatosis and liver injury in a mouse model of non-alcoholic fatty liver disease.
    Journal of hepatology, 2013, Volume: 58, Issue:4

    Topics: Alanine Transaminase; Animals; Apoptosis; Benzothiazoles; Cell Line; Diet, High-Fat; Disease Models,

2013